You are here

Article Text

Article menu
Download PDFPDF
Case Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation)
Image-guided percutaneous cryoablation of a solitary subpleural lung metastasis from breast cancer
  1. John Valtersson1,
  2. Marianne Vogsen2,
  3. Ole Graumann3,1 and
  4. Pia Iben Pietersen3,1
  1. 1UNIFY - Research and Innovation Unit of Radiology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark
  2. 2Department of Oncology, Odense University Hospital, Odense, Denmark
  3. 3Department of Radiology, Odense University Hospital, Odense, Denmark
  1. Correspondence to Dr Pia Iben Pietersen; pia.iben.pietersen3{at}rsyd.dk

Abstract

This case presents CT-guided percutaneous cryoablation as a treatment option in a patient with oligometastatic breast cancer who previously had received standard-of-care treatment for metastatic breast cancer. Before cryoablation, the patient received two systemic lines of therapy, several surgeries and radiotherapy for oligometastatic disease. The cryoablation was performed in a single 7 mm subpleural oligometastatic lesion 42 months after diagnosis of metastatic breast cancer. It was performed without complications, and the patient experienced no complaints or discomfort after the procedure. A 3-month, 6-month, 9-month and 12-month follow-up fluorodeoxyglucose-positron emission tomography/CT scans showed no sign of disease progression.

  • Interventional radiology
  • Radiology
  • Breast cancer

https://doi.org/10.1136/bcr-2023-256256

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Twitter @PiaIben

    • Contributors Substantial contribution to conception and design: JV, MV, OG and PIP. Substantial contribution to acquisition of data: JV, OG and PIP. Substantial contribution to analysis and interpretation of data: JV, MV, OG and PIP. Drafting the article: JV and PIP. Critically revising the article for important intellectual content: MV and OG. Final approval of the version to be published: JV, MV, OG and PIP.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.